These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 21396839

  • 21. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK, Zhang WW, Trachtenberg J, Seth A, Klotz LH, Stanimirovic A, Punnen S, Venkateswaran V, Toi A, Loblaw DA, Sugar L, Siminovitch KA, Narod SA.
    Clin Cancer Res; 2009 Mar 01; 15(5):1787-93. PubMed ID: 19223501
    [Abstract] [Full Text] [Related]

  • 22. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
    Peters CA, Stock RG, Blacksburg SR, Stone NN.
    Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):24-9. PubMed ID: 18692325
    [Abstract] [Full Text] [Related]

  • 23. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J.
    Cancer Epidemiol Biomarkers Prev; 2004 May 01; 13(5):759-64. PubMed ID: 15159307
    [Abstract] [Full Text] [Related]

  • 24. The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.
    Lose F, Lawrence MG, Srinivasan S, O'Mara T, Marquart L, Chambers S, Gardiner RA, Aitken JF, Spurdle AB, Batra J, Clements JA, Australian Prostate Cancer BioResource.
    Biol Chem; 2012 Apr 01; 393(5):403-12. PubMed ID: 22505522
    [Abstract] [Full Text] [Related]

  • 25. Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in a Northern Han Chinese population.
    Zhang Y, Wang Y, Zhai M, Gan T, Zhao X, Zhang R, An T, Huang Y, Zhou Q, Zhang J.
    Gene; 2018 Feb 05; 642():293-298. PubMed ID: 29129812
    [Abstract] [Full Text] [Related]

  • 26. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis.
    Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S, Harris CC.
    Int J Cancer; 2006 Apr 01; 118(7):1790-7. PubMed ID: 16217767
    [Abstract] [Full Text] [Related]

  • 27. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
    Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B.
    Carcinogenesis; 2006 Mar 01; 27(3):606-9. PubMed ID: 16251207
    [Abstract] [Full Text] [Related]

  • 28. Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway.
    Lévesque E, Laverdière I, Audet-Walsh E, Caron P, Rouleau M, Fradet Y, Lacombe L, Guillemette C.
    Clin Cancer Res; 2014 Jun 01; 20(11):2971-83. PubMed ID: 24682418
    [Abstract] [Full Text] [Related]

  • 29. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
    Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei Q.
    Hum Mutat; 2008 Dec 01; 29(12):1443-51. PubMed ID: 18563783
    [Abstract] [Full Text] [Related]

  • 30. Single-nucleotide polymorphisms studied for associations with urinary toxicity from (125)I prostate brachytherapy implants.
    Usmani N, Leong N, Martell K, Lan L, Ghosh S, Pervez N, Pedersen J, Yee D, Murtha A, Amanie J, Sloboda R, Murray D, Parliament M.
    Brachytherapy; 2014 Dec 01; 13(3):285-91. PubMed ID: 24656733
    [Abstract] [Full Text] [Related]

  • 31. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
    Kuhlmann JD, Bankfalvi A, Schmid KW, Callies R, Kimmig R, Wimberger P, Siffert W, Bachmann HS.
    BMC Cancer; 2016 Aug 09; 16():618. PubMed ID: 27507139
    [Abstract] [Full Text] [Related]

  • 32. When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.
    Li-Wan-Po A, Farndon P, Cooley C, Lithgow J.
    Public Health Genomics; 2010 Aug 09; 13(1):55-62. PubMed ID: 19439915
    [Abstract] [Full Text] [Related]

  • 33. Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancer.
    Liu K, Li X, Wang J, Wang Y, Dong H, Li J.
    Oncotarget; 2017 Mar 21; 8(12):19298-19309. PubMed ID: 28184030
    [Abstract] [Full Text] [Related]

  • 34. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.
    Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS.
    J Urol; 2013 Jul 21; 190(1):102-8. PubMed ID: 23376709
    [Abstract] [Full Text] [Related]

  • 35. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
    Corrado A, Aceto R, Silvestri R, Dell'Anno I, Ricci B, Miglietta S, Romei C, Giovannoni R, Poliseno L, Evangelista M, Vitiello M, Cipollini M, Garritano S, Giusti L, Zallocco L, Elisei R, Landi S, Gemignani F.
    Thyroid; 2021 Jul 21; 31(7):1056-1066. PubMed ID: 33308024
    [Abstract] [Full Text] [Related]

  • 36. Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
    Bachmann HS, Heukamp LC, Schmitz KJ, Hilburn CF, Kahl P, Buettner R, Nückel H, Eisenhardt A, Rübben H, Schmid KW, Siffert W, Eggert A, Schramm A, Schulte JH.
    Int J Cancer; 2011 Nov 15; 129(10):2390-9. PubMed ID: 21207420
    [Abstract] [Full Text] [Related]

  • 37. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
    FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL.
    Cancer Epidemiol Biomarkers Prev; 2011 Jun 15; 20(6):1196-203. PubMed ID: 21467234
    [Abstract] [Full Text] [Related]

  • 38. Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer.
    Ulybina YM, Kuligina ES, Mitiushkina NV, Rozanov ME, Ivantsov AO, Ponomariova DN, Togo AV, Levchenko EV, Shutkin VA, Brenister SI, Devilee P, Zhivotovsky B, Hirvonen A, Imyanitov EN.
    Cancer Lett; 2009 Jun 18; 278(2):183-191. PubMed ID: 19203830
    [Abstract] [Full Text] [Related]

  • 39. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
    Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS.
    Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):e21-8. PubMed ID: 23021708
    [Abstract] [Full Text] [Related]

  • 40. Prostate cancer risk is not altered by TP53AIP1 germline mutations in a German case-control series.
    Luedeke M, Coinac I, Linnert CM, Bogdanova N, Rinckleb AE, Schrader M, Vogel W, Hoegel J, Meyer A, Dörk T, Maier C.
    PLoS One; 2012 Jan 01; 7(3):e34128. PubMed ID: 22457820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.